• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Search results from the "OB_Rx" table for query on "021567."



Active Ingredient: ATAZANAVIR SULFATE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REYATAZ
Applicant: BRISTOL MYERS SQUIBB
Strength: EQ 100MG BASE
Application Number: N021567
Product Number: 001
Approval Date: Jun 20, 2003
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code: AB
Patent and Exclusivity Info for this product: View

Active Ingredient: ATAZANAVIR SULFATE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REYATAZ
Applicant: BRISTOL MYERS SQUIBB
Strength: EQ 150MG BASE
Application Number: N021567
Product Number: 002
Approval Date: Jun 20, 2003
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code: AB
Patent and Exclusivity Info for this product: View

Active Ingredient: ATAZANAVIR SULFATE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REYATAZ
Applicant: BRISTOL MYERS SQUIBB
Strength: EQ 200MG BASE
Application Number: N021567
Product Number: 003
Approval Date: Jun 20, 2003
Reference Listed Drug No
RX/OTC/DISCN: RX
TE Code: AB
Patent and Exclusivity Info for this product: View

Active Ingredient: ATAZANAVIR SULFATE
Dosage Form;Route: CAPSULE;ORAL
Proprietary Name: REYATAZ
Applicant: BRISTOL MYERS SQUIBB
Strength: EQ 300MG BASE
Application Number: N021567
Product Number: 004
Approval Date: Oct 16, 2006
Reference Listed Drug Yes
RX/OTC/DISCN: RX
TE Code: AB
Patent and Exclusivity Info for this product: View

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through July 2014
Patent and Generic Drug Product Data Last Updated August 29, 2014

-
-